Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Stanford s Reynolds Center Collaborate on Heart Disease Research

NEW YORK, Oct. 3 (GenomeWeb News) - Agilent Technologies said today that it has formed a collaboration with Stanford University's Donald W. Reynolds Cardiovascular Clinical Research Center to study the basic mechanisms of heart disease.

 

Under the arrangement, the partners will use Agilent's gene expression and computational technologies to identify, characterize, and validate potential diagnostic and drug targets that could help prevent, diagnosis, and treat heart disease.

 

"Collaborating with Agilent ... gives us access to a DNA microarray platform that provides leading-edge sensitivity and reproducibility, as well as accomplished molecular biologists who help us optimize our gene-expression experiments," Thomas Quertermous, the William G. Irwin professor and chief of research in Stanford's division of cardiovascular medicine, said in a statement.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.